DocSym
β
Searchsearch
Search
(P04.0) Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
More details coming soon
328 392 in individuals diagnosis fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery confirmed
2 715 deaths with diagnosis fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
1% mortality rate associated with the disease fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
Diagnosis fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery is diagnosed Men are 5.67% more likely than Women
173 513
Men receive the diagnosis fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
2 715 (1.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
154 879
Women receive the diagnosis fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery - Men and Women aged 0
In Men diagnosis is most often set at age 0-1
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-5, 10-95+
In Women diagnosis is most often set at age 0-1, 5-9
Disease Features fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
Absence or low individual and public risk
Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery - what does this mean
Maternal anaesthesia and analgesia in pregnancy, labour and delivery can cause fetal and newborn effects due to the transfer of the anaesthetic and analgesic agents to the fetus through the placenta. this can cause the fetus to become sedated and can lead to newborn depression, asphyxia, and even death in severe cases.
What happens during the disease - fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery
The pathogenesis of this condition is likely related to the transfer of anaesthetics and analgesics from the mother to the fetus via the placenta. these drugs can pass through the placenta and into the fetal circulation, where they can cause a range of adverse effects, including depression of the central nervous system, respiratory depression, and increased risk of intrauterine death. in addition, the drugs can also affect the newborn's ability to adapt to the extrauterine environment, leading to longer-term effects such as neurodevelopmental problems.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Obtain a detailed history of the mother's medication use during pregnancy, labour, and delivery.
- Conduct a physical exam of the fetus/newborn to look for signs of drug-induced effects.
- Order laboratory tests to determine the presence of drugs in the newborn's system.
- Conduct imaging studies, such as ultrasounds or X-rays, to assess the fetus/newborn's development.
- Perform a neurological exam to evaluate the newborn's reflexes and muscle tone.
- Assess the newborn's hearing and vision.
- Monitor the newborn's vital signs, such as heart rate and breathing, and look for any signs of distress.
- Consult with a specialist, such as a neonatologist or pediatrician, for further evaluation.
Treatment and Medical Assistance
Main Goal: To reduce the risk of complications due to maternal anaesthesia and analgesia in pregnancy, labour and delivery for the fetus and newborn.
- Monitoring of fetal health during labour and delivery
- Administering oxygen to the newborn
- Administering medications to reduce the risk of respiratory depression
- Ensuring proper positioning of the fetus during delivery
- Monitoring the newborn's vital signs
- Administering antibiotics to prevent infection
- Providing supportive care to the newborn
- Providing nutrition to the newborn
- Providing psychological support to the mother and family
- Providing education to the mother and family about the risks of maternal anaesthesia and analgesia in pregnancy, labour and delivery
9 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery - Prevention
The best way to prevent fetal and newborns from being affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery is to ensure that anaesthesia and analgesia are only used when absolutely necessary, and that the dose and duration of the drugs are carefully monitored and adjusted according to the individual needs of the mother and fetus. additionally, pregnant women should be informed about the potential risks and benefits of these drugs, and should always consult with their doctor before taking them.